Tibet Rhodiola Pharmaceutical Holding Dividend
Dividend criteria checks 5/6
Tibet Rhodiola Pharmaceutical Holding is a dividend paying company with a current yield of 3.03% that is well covered by earnings.
Key information
3.0%
Dividend yield
59%
Payout ratio
Industry average yield | 1.6% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | CN¥2.52 |
Dividend yield forecast in 3Y | 0% |
Recent dividend updates
No updates
Recent updates
Tibet Rhodiola Pharmaceutical Holding (SHSE:600211) Seems To Use Debt Rather Sparingly
May 21Shareholders Will Be Pleased With The Quality of Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Earnings
May 03Under The Bonnet, Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Returns Look Impressive
Mar 22Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 600211's dividend payments have been volatile in the past 10 years.
Growing Dividend: 600211's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
Tibet Rhodiola Pharmaceutical Holding Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (600211) | 3.0% |
Market Bottom 25% (CN) | 0.6% |
Market Top 25% (CN) | 2.2% |
Industry Average (Healthcare) | 1.6% |
Analyst forecast in 3 Years (600211) | 0% |
Notable Dividend: 600211's dividend (3.03%) is higher than the bottom 25% of dividend payers in the CN market (0.64%).
High Dividend: 600211's dividend (3.03%) is in the top 25% of dividend payers in the CN market (2.23%)
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (59.3%), 600211's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (33.3%), 600211's dividend payments are well covered by cash flows.